Caplin Point Laboratories Limited
Caplin Point Laboratories Ltd is engaged in the manufacturing and sourcing of APIs, finished formulations, R&D, clinical research with presence in Latin America, Africa, USA and other nations.
What Caplin files
- Others44
- Investor Meet25
- Important14
- Updates14
- Board Meeting7
- Dividend/Bonus5
Caplin Point Laboratories Limited has informed the Exchange about Copy of Newspaper Publication
Caplin Point is ensuring all shareholders can access its upcoming Annual General Meeting (AGM) and Annual Report. Letters with a weblink are being sent to those without registered emails, enabling online access to key documents.
Company filed its FY26 Business Responsibility and Sustainability Report. It expanded its global footprint by acquiring new subsidiaries in Chile and Mexico. The firm achieved 36.65% renewable power usage and 52.39% water recycling. New sustainability targets aim for 50% solar energy and 45% women's workforce participation. CSR spending reached ₹4.70...
Caplin Point Laboratories Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 25, 2026
Significant increase in volume has been observed in Caplin Point Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Caplin Point Laboratories...